Search results
Novartis Patient Information Leaked in Third-Party Data Breach at Lash Group | JD Supra
JD Supra· 10 minutes agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access sensitive information belonging to patients enrolled in “patient support programs ...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 5 hours agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 3 days agoUBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities ...
Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 4 days agoLevel Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the company in its most ...
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
Zacks· 14 hours agoFree Report) lost more than 17% on May 23 after it announced a funding deal with Royalty Pharma...
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs - Indianapolis...
Indianapolis Business Journal· 4 days agoA Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via Yahoo Finance· 41 minutes agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 1 day agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 4 hours agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 1 day agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...